Hem Securities is bullish on Greenpanel Industries has recommended buy rating on the stock with a target price of Rs 552 in its research report dated September 06, 2022.
Posts tagged MC
Buy Greenpanel Industries; target of Rs 552: Hem Securities (08-09-2022)
Buy MapMyIndia; target of Rs 1700: Anand Rathi (07-09-2022)
Anand Rathi is bullish on MapMyIndia has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated September 06, 2022.
Buy Action Construction Equipment; target of Rs 365: ICICI Direct (07-09-2022)
ICICI Direct is bullish on Action Construction Equipment has recommended buy rating on the stock with a target price of Rs 365 in its research report dated September 07, 2022.
Buy Narayana Hrudayalaya; target of Rs 810: Prabhudas Lilladher (07-09-2022)
Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 810 in its research report dated September 06, 2022.
Buy Narayana Hrudayalaya; target of Rs 810: Prabhudas Lilladher (07-09-2022)
Prabhudas Lilladher is bullish on Narayana Hrudayalaya has recommended buy rating on the stock with a target price of Rs 810 in its research report dated September 06, 2022.
Buy Bharti Airtel; target of Rs 1032: Prabhudas Lilladher (07-09-2022)
Prabhudas Lilladher is bullish on Bharti Airtel has recommended buy rating on the stock with a target price of Rs 1032 in its research report dated September 05, 2022.
Buy Gail (India); target of Rs 110: ICICI Direct (07-09-2022)
ICICI Direct is bullish on Gail (India) has recommended buy rating on the stock with a target price of Rs 110 in its research report dated September 06, 2022.
Aarti Industries: Capex cycle likely to act as a tonic (07-09-2022)
Near-term challenge impacting the company’s performance is the shortage of key raw material nitric acid. This can be troubling for the next 6-12 months till the time new domestic capacities come on stream.
Bajaj Healthcare: Weak Q1 not a dampener for long run (07-09-2022)
Capacity ramp-up and new business opportunities should stand Bajaj Healthcare in good stead; any correction a scope to buy
Buy IndusInd Bank; target of Rs 1300: Anand Rathi (06-09-2022)
Anand Rathi is bullish on IndusInd Bank has recommended buy rating on the stock with a target price of Rs 1300 in its research report dated September 05, 2022.